CMP: 40

Twilight Litaka Pharma Ltd manufactures drugs and formulations in the form of tablets, capsules, ointment and liquids.

Twilight Litaka is a 100 Crore penny cap stock. Its currently trading at a P/E of 2 with exceedingly good dividend yields of almost 4% in the last 12 months. The low P/E is compensated for by the high liabilities. Revenues have been strong and consistently growing from 197 Crores to 656 Crores in the last 5 years. Profits have grown in similar lines from 14 Crores to almost 50 Crores in the same period. NPM has risen marginally from 7% to 7.50% over 5 years. Considering recession lows of 23 and profit growth of over 100% since then, current levels are exceedingly attractive.